Dubious benefits of dual antiplatelet therapy after coronary surgery: new evidence in 2201 patients
A prospective randomized study including more than 2000 patients compared the outcomes of single antiplatelet therapy with aspirin versus dual antiplatelet therapy with aspirin and ticagrelor during the year following coronary artery bypass grafting (CABG) performed for acute coronary syndrome (ACS).